Tradestie Institutional Equity Comparison Engine · Market Close May 26, 2026

IPOD vs ABL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABL Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

ABL Overall Winner 6-Pillar Tally: IPOD 0 – 5 ABL (1 Tie) Matrix Metrics: IPOD 3 – 7 ABL

As of May 26, 2026, Abacus Global Management, Inc. (ABL) is the stronger overall head-to-head candidate over IPOD (IPOD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABL carries 61.3/100 (BUY) at $8.47 (8.6x Forward P/E, 35.6% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IPOD vs ABL
IPOD US Equity
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 2% Vol
Unified Composite Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
ABL NASDAQ Head-to-Head Winner
Abacus Global Management, Inc. Class A Common Stock
Investment Advice
$8.47
-0.35% 1D
Market Cap $830.9M
TTM Revenue $87M
Forward P/E 8.6x
Beta / 30D Vol 1.19β · 48% Vol
Unified Composite Score
61.3 / 100 BUY
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (13.4% over 20 days), RSI 68
RSI-14: 67.8 · SMA20: $7.89 · SMA50: $6.67

6-Pillar Scorecard Institutional Category Breakdown (IPOD 0 – 5 ABL)

Columns: Metric · IPOD · ABL
1. Valuation Multiples ABL
Forward P/E N/M 8.6x
Trailing P/E 39.9x N/M
PEG Ratio N/M N/M
EV / Revenue N/M 9.6x
2. Growth & Scale ABL
Revenue Growth (YoY) +0.0% +123.7%
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) N/A $87M
Market Cap $210.0M $830.9M
3. Profitability & Quality ABL
Gross Margin N/A 87.5%
Operating Margin 0.0% 35.6%
Net Profit Margin 0.0% 5.6%
Return on Equity (ROE) 0.0% 3.2%
4. Balance Sheet & Cash Flow ABL
Cash Generation (TTM) N/A $32M EBITDA
Cash Flow Margin N/A 36.7% EBITDA Mgn
Net Cash / Leverage 0.0% ROE $4.45 Book/Sh · 3.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 52.0% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat ABL
OpEx & R&D Intensity N/A 51.9% of Rev ($45M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Shell Companies Operator Insurance - Life Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IPOD (3) vs ABL (7)
Institutional Metric IPOD ABL Criterion Row Edge
Market Capitalization
Scale
$210.0M $830.9M Larger Scale ABL
Trailing P/E Ratio
Valuation
39.9x N/M Lower Multiple IPOD
Forward P/E Ratio
Valuation
N/M 8.6x Lower Multiple ABL
Revenue Growth (YoY)
Growth
+0.0% +123.7% Higher Growth ABL
Operating Margin (TTM)
Profitability
0.0% 35.6% Higher Margin ABL
Net Profit Margin
Profitability
0.0% 5.6% Higher Margin ABL
Return on Equity (ROE)
Capital Efficiency
0.0% 3.2% Higher ROE ABL
52-Week Range Position
Momentum
100% ($10–$10) 77% ($5–$10) Stronger Trend IPOD
Beta / 30D Volatility
Risk Regime
0.00β · 2% Vol 1.19β · 48% Vol Lower Realized Risk IPOD
Unified Institutional Score
Composite Signal
58.0 / 100 (HOLD) 61.3 / 100 (BUY) Higher Composite ABL
Trailing 12M Revenue (USD)
Operating Scale
N/A $87M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 87.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 9.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) $32M EBITDA ($4.45 Book/Sh · 3.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABL +58.4 pp
IPOD: +0.51% · ABL: +58.91%
3M Horizon ABL +57.73 pp
IPOD: +1.48% · ABL: +59.21%
6M Horizon ABL +43.37 pp
IPOD: +1.66% · ABL: +45.03%
1Y Horizon ABL +43.37 pp
IPOD: +1.66% · ABL: +45.03%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs ABL. Trailing 12-month operating profitability (IPOD 0.0% vs ABL 35.6%) and valuation multiples (IPOD N/M vs ABL 8.6x Forward P/E) are benchmarked directly in Pillar 4 below.

IPOD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
ABL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$87M
Gross Margin87.5%
Op. Margin35.6%
ROE / Fwd P/E3.2% · 8.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IPOD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPOD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 52.0%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IPOD Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABL Moat Profile High-Margin Pricing Power Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with $830.9M market capitalization and 35.6% operating margin.
OpEx & R&D Reinvestment 51.9% of Rev ($45M)
90D Engineering Disclosures 0 Published

Investor FAQ IPOD vs ABL Key Questions & Quantitative Answers

As of May 26, 2026, Abacus Global Management, Inc. (ABL) is the stronger overall head-to-head candidate over IPOD (IPOD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABL carries 61.3/100 (BUY) at $8.47 (8.6x Forward P/E, 35.6% operating margin). Technically, IPOD sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and ABL sits in a Markup phase (RSI 67.8, UNCLASSIFIED options structure).

ABL leads the Growth & Scale pillar: IPOD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ABL at +123.7% YoY revenue growth and N/A YoY earnings growth on $87M TTM revenue (87.5% gross margin, 35.6% operating margin). On trailing 12-month operating scale, IPOD generates N/A in USD-normalized revenue versus $87M for ABL. In operating R&D and SG&A reinvestment, IPOD deploys N/A (0 90-day corporate R&D disclosures) versus 51.9% of Rev ($45M) (0 disclosures) for ABL.

ABL screens cheaper on headline valuation multiples. IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABL trades at 8.6x Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (36.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPOD (0.0% ROE) versus ABL (3.2% ROE) capital efficiency.

In options market volatility and institutional positioning, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk). By comparison, ABL carries 52.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of May 26, 2026. For educational research only; not investment advice.